188 related articles for article (PubMed ID: 15763458)
1. Incidental lung cancers identified at coronial autopsy: implications for overdiagnosis of lung cancer by screening.
Manser RL; Dodd M; Byrnes G; Irving LB; Campbell DA
Respir Med; 2005 Apr; 99(4):501-7. PubMed ID: 15763458
[TBL] [Abstract][Full Text] [Related]
2. Pathologic review of the Mayo Lung Project cancers [corrected]. Is there a case for misdiagnosis or overdiagnosis of lung carcinoma in the screened group?
Colby TV; Tazelaar HD; Travis WD; Bergstralh EJ; Jett JR
Cancer; 2002 Dec; 95(11):2361-5. PubMed ID: 12436443
[TBL] [Abstract][Full Text] [Related]
3. A critical appraisal of overdiagnosis: estimates of its magnitude and implications for lung cancer screening.
Reich JM
Thorax; 2008 Apr; 63(4):377-83. PubMed ID: 18364449
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography.
Sone S; Nakayama T; Honda T; Tsushima K; Li F; Haniuda M; Takahashi Y; Suzuki T; Yamanda T; Kondo R; Hanaoka T; Takayama F; Kubo K; Fushimi H
Lung Cancer; 2007 Dec; 58(3):329-41. PubMed ID: 17675180
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
6. Outcome of patients with lung cancer detected incidentally.
Kanashiki M; Satoh H; Ishikawa H; Ohtsuka M; Sekizawa K
Oncol Rep; 2004 Oct; 12(4):945-8. PubMed ID: 15375527
[TBL] [Abstract][Full Text] [Related]
7. Reliability of cytologic diagnosis of early lung cancer.
Vazquez MF; Koizumi JH; Henschke CI; Yankelevitz DF
Cancer; 2007 Aug; 111(4):252-8. PubMed ID: 17614298
[TBL] [Abstract][Full Text] [Related]
8. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia.
Port ER; Park A; Borgen PI; Morris E; Montgomery LL
Ann Surg Oncol; 2007 Mar; 14(3):1051-7. PubMed ID: 17206485
[TBL] [Abstract][Full Text] [Related]
9. Is palpation of the nonresected pulmonary lobe(s) required for patients with non-small cell lung cancer? A prospective study.
Cerfolio RJ; Bryant AS
J Thorac Cardiovasc Surg; 2008 Feb; 135(2):261-8. PubMed ID: 18242247
[TBL] [Abstract][Full Text] [Related]
10. Misdiagnosis of lung cancer in a 2000 consecutive autopsy study in Budapest.
Kendrey G; Szende B; Lapis K; Marton T; Hargitai B; Roe FJ; Lee PN
Gen Diagn Pathol; 1996 Mar; 141(3-4):169-78. PubMed ID: 8705779
[TBL] [Abstract][Full Text] [Related]
11. Incidence and clinical characteristics of symptomatic choroidal metastasis from lung cancer.
Kreusel KM; Bechrakis NE; Wiegel T; Krause L; Foerster MH
Acta Ophthalmol; 2008 Aug; 86(5):515-9. PubMed ID: 18081901
[TBL] [Abstract][Full Text] [Related]
12. Computed tomographic screening for lung cancer: the relationship of disease stage to tumor size.
Henschke CI; Yankelevitz DF; Miettinen OS;
Arch Intern Med; 2006 Feb; 166(3):321-5. PubMed ID: 16476872
[TBL] [Abstract][Full Text] [Related]
13. Comparison of observed and expected numbers of detected cancers in the research center for cancer prevention and screening program.
Hamashima C; Sobue T; Muramatsu Y; Saito H; Moriyama N; Kakizoe T
Jpn J Clin Oncol; 2006 May; 36(5):301-8. PubMed ID: 16735372
[TBL] [Abstract][Full Text] [Related]
14. Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status.
Ou SH; Zell JA; Ziogas A; Anton-Culver H
Cancer; 2008 May; 112(9):2011-20. PubMed ID: 18361399
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer screening--comparison of computed tomography and X-ray.
Fujikawa A; Takiguchi Y; Mizuno S; Uruma T; Suzuki K; Nagao K; Niijima M; Edo H; Hino M; Kuriyama T
Lung Cancer; 2008 Aug; 61(2):195-201. PubMed ID: 18242764
[TBL] [Abstract][Full Text] [Related]
16. Urban-rural differences in the management of screen-detected invasive breast cancer and ductal carcinoma in situ in victoria.
Kok DL; Chang JH; Erbas B; Fletcher A; Kavanagh AM; Henderson MA; Gertig DM
ANZ J Surg; 2006 Nov; 76(11):996-1001. PubMed ID: 17054549
[TBL] [Abstract][Full Text] [Related]
17. Detection sensitivity of a commercial lung nodule CAD system in a series of pathologically proven lung cancers.
Godoy MC; Cooperberg PL; Maizlin ZV; Yuan R; McWilliams A; Lam S; Mayo JR
J Thorac Imaging; 2008 Feb; 23(1):1-6. PubMed ID: 18347512
[TBL] [Abstract][Full Text] [Related]
18. Lung cancer incidence in middle-aged men estimated by low-dose computed tomography screening.
Nojo T; Imanaka Y; Ishizaki T; Sekimoto M; Yoshino M; Kurosawa T; Takao H; Ohtomo K
Lung Cancer; 2009 Jul; 65(1):56-61. PubMed ID: 19019487
[TBL] [Abstract][Full Text] [Related]
19. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
